- Report
- July 2025
- 168 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- May 2025
- 186 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- July 2024
- 120 Pages
Global
From €5390EUR$5,950USD£4,646GBP
- Report
- April 2023
- 119 Pages
Global
From €4077EUR$4,500USD£3,514GBP
- Report
- November 2021
- 270 Pages
Global
From €2265EUR$2,500USD£1,952GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more